• 1
    Kasitanon N, Magder LS, Petri M.Predictors of survival in systemic lupus erythematosus.Medicine (Baltimore)2006;85:14756.
  • 2
    Ward MM.Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.J Rheumatol2009;36:637.
  • 3
    Nashi E, Wang Y, Diamond B.The role of B cells in lupus pathogenesis.Int J Biochem Cell Biol2010;42:54350.
  • 4
    Rovin BH.Targeting B-cells in lupus nephritis: should cautious optimism remain?Nephrol Dial Transplant2013;28:79.
  • 5
    Gregersen JW, Jayne DR.B-cell depletion in the treatment of lupus nephritis.Nat Rev Nephrol2012;8:50514.
  • 6
    Weidenbusch M, Rommele C, Schrottle A, Anders HJ.Beyond the LUNAR trial: efficacy of rituximab in refractory lupus nephritis.Nephrol Dial Transplant201; 28:10611.
  • 7
    Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, FitzGerald JD, et al.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.Arthritis Care Res (Hoboken)2012;64:797808.
  • 8
    Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al.Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Ann Rheum Dis2012;71:177182.
  • 9
    Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, et al.Defective B cell development and function in Btk-deficient mice.Immunity1995;3:28399.
  • 10
    Satterthwaite AB, Cheroutre H, Khan WN, Sideras P, Witte ON.Btk dosage determines sensitivity to B cell antigen receptor cross-linking.Proc Natl Acad Sci U S A1997;94:131527.
  • 11
    Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al.Primary B cell immunodeficiencies: comparisons and contrasts.Annu Rev Immunol2009;27:199227.
  • 12
    Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, et al.Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice.Blood2012;119:374456.
  • 13
    Lee KG, Xu S, Kang ZH, Huo J, Huang M, Liu D, et al.Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response.Proc Natl Acad Sci U S A2012;109:57916.
  • 14
    Lee KG, Xu S, Wong ET, Tergaonkar V, Lam KP.Bruton's tyrosine kinase separately regulates NFκB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells.J Biol Chem2008;283:1118998.
  • 15
    Middendorp S, Dingjan GM, Hendriks RW.Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice.J Immunol2002;168:2695703.
  • 16
    Xu D, Kim Y, Postelnek J, Vu MD, Hu DQ, Liao C, et al.RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.J Pharmacol Exp Ther2012;341:90103.
  • 17
    Halcomb KE, Musuka S, Gutierrez T, Wright HL, Satterthwaite AB.Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.Mol Immunol2008;46:23341.
  • 18
    Perry D, Sang A, Yin Y, Zheng YY, Morel L.Murine models of systemic lupus erythematosus.J Biomed Biotechnol2011;2011:271694.
  • 19
    Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, et al.Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis.J Immunol2012;189:9881001.
  • 20
    Hoyer BF, Moser K, Hauser AE, Peddinghaus A, Voigt C, Eilat D, et al.Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.J Exp Med2004;199:157784.
  • 21
    Reininger L, Winkler TH, Kalberer CP, Jourdan M, Melchers F, Rolink AG.Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.J Exp Med1996;184:85361.
  • 22
    Haas KM, Watanabe R, Matsushita T, Nakashima H, Ishiura N, Okochi H, et al.Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.J Immunol2010;184:4789800.
  • 23
    Davidson A, Aranow C.Lupus nephritis: lessons from murine models.Nat Rev Rheumatol2010;6:1320.
  • 24
    Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, et al.Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.J Immunol2008;180:193847.
  • 25
    Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, et al.A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.J Immunol2011;186:49945003.
  • 26
    Hill GS, Delahousse M, Nochy D, Remy P, Mignon F, Mery JP, et al.Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.Kidney Int2001;59:30416.
  • 27
    Iwata Y, Bostrom EA, Menke J, Rabacal WA, Morel L, Wada T, et al.Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.J Immunol2012;188:456880.
  • 28
    Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, et al.The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy.Proc Natl Acad Sci U S A2010;107:1307580.
  • 29
    Smith DL, Dong X, Du S, Oh M, Singh RR, Voskuhl RR.A female preponderance for chemically induced lupus in SJL/J mice.Clin Immunol2007;122:1017.
  • 30
    Chang NH, Cheung YH, Loh C, Pau E, Roy V, Cai YC, et al.B cell activating factor (BAFF) and T cells cooperate to breach B cell tolerance in lupus-prone New Zealand Black (NZB) mice.PLoS One2010;5:e11691.
  • 31
    Bloom RD, Florquin S, Singer GG, Brennan DC, Kelley VR.Colony stimulating factor-1 in the induction of lupus nephritis.Kidney Int1993;43:10009.
  • 32
    Crow MK, Kirou KA, Wohlgemuth J.Microarray analysis of interferon-regulated genes in SLE.Autoimmunity2003;36:48190.
  • 33
    Crow MK, Wohlgemuth J.Microarray analysis of gene expression in lupus.Arthritis Res Ther2003;5:27987.
  • 34
    Reddy PS, Legault HM, Sypek JP, Collins MJ, Goad E, Goldman SJ, et al.Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis.Arthritis Res Ther2008;10:R127.
  • 35
    Barrionuevo P, Beigier-Bompadre M, De La Barrera S, Alves-Rosa MF, Fernandez G, Palermo MS, et al.Immune complexes (IC) down-regulate the basal and interferon-γ-induced expression of MHC class II on human monocytes.Clin Exp Immunol2001;125:2517.
  • 36
    Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, et al.Anti–tumor necrosis factor α treatment of interferon-γ–induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.Arthritis Rheum2012;64:3399408.
  • 37
    Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY, et al.Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity.J Autoimmun2012;39:1808.
  • 38
    Fukuyama H, Nimmerjahn F, Ravetch JV.The inhibitory Fcγ receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells.Nat Immunol2005;6:99106.
  • 39
    Martin F, Kearney JF.Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.Immunity2000;12:3949.
  • 40
    Schmidt NW, Thieu VT, Mann BA, Ahyi AN, Kaplan MH.Bruton's tyrosine kinase is required for TLR-induced IL-10 production.J Immunol2006;177:720310.
  • 41
    Kawakami Y, Inagaki N, Salek-Ardakani S, Kitaura J, Tanaka H, Nagao K, et al.Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3.Proc Natl Acad Sci U S A2006;103:1538.
  • 42
    Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M.Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.J Exp Med1994;179:30510.
  • 43
    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, et al.IL-10 regulates murine lupus.J Immunol2002;169:214855.
  • 44
    Tsukamoto Y, Nagai Y, Kariyone A, Shibata T, Kaisho T, Akira S, et al.Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.Mol Immunol2009;46:127888.
  • 45
    Cassese G, Lindenau S, de Boer B, Arce S, Hauser A, Riemekasten G, et al.Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells.Eur J Immunol2001;31:272632.
  • 46
    Joo H, Coquery C, Xue Y, Gayet I, Dillon SR, Punaro M, et al.Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.J Exp Med2012;209:133548.